Venture Capital

As traditional milk consumption evolves, the California Milk Advisory Board is acting like a Silicon Valley VC, funding high-growth CPG startups to secure the future of dairy.

ReSpark’s acquisition of ScrapRight marks its third major deal in six months. Helen Davis explores how venture capital is transforming metal recycling.

A €12M Series A for German biotech ViferaXS highlights a strategic shift in European sovereign funding and the rise of the tech-bio equity playbook.

With traditional hardware accelerators dormant, a legendary design studio is embedding senior experts directly onto startup cap tables to de-risk physical innovation.

Karimah Es Sabar, a titan who has raised over $1.5B in bioscience, joins Linearis Ventures. This move signals a major bet on a new model for health-tech investing.

A new boot camp aims to bridge the critical funding gap for early-stage space and defense companies, shifting focus from government contracts to investment readiness.

Europe is flush with scale-up cash but struggles to create giants. A new data-driven initiative in Slovenia aims to solve this, but is it enough?

As global VCs retreat, Canada's tech startups are more reliant on US funding than ever. Is this a life raft or a strategic risk for the nation's future?

With wins from the Cerebras and SpaceX IPOs, Open Doors Partners hires Ravi Chiruvolu to deepen its expertise in a pivotal moment for private markets.

The iconic business publisher joins Mercurius Media Capital, trading ad space for startup equity in a move that could redefine venture funding for a new era.

A new class of athlete is trading endorsements for equity. The addition of MLB stars Jon Jay and Tyson Ross to BrknPar Ventures isn't just a headline—it's a sign of a fundamental shift in venture capital.

MDB Capital celebrates a string of successful IPOs but reports a staggering $16.1M loss, putting its unique 'public venture' model under intense scrutiny.

While venture fundraising slows, GEM oversubscribes its new seed fund. Brian Nelson analyzes how the firm is leveraging market fragmentation to back the next wave of innovators.

Joe Benevento's C-Suite award is more than a trophy; it's a marker for Virginia's stunning rise as a tech hub. We dig into the numbers and strategy.

Amid market shifts, Northern 3 VCT posts strong NAV growth. A deep dive reveals a dual strategy: investing in AI pioneers and cashing in on past wins.

As AI reshapes the threat landscape, VC firm Costanoa brings in ex-Uber and Meta CSO Joe Sullivan. A look at why operational expertise is the new currency in cybersecurity investing.

A team of medtech veterans, fresh off a $585M exit to Medtronic, just launched NovoMed PARTNERS. Their operator-led model could rewrite the rules.

JumpStart VC Fest is more than a conference. It's a strategic engine designed to funnel capital and talent into the Midwest, challenging Silicon Valley's grip.

Novartis's acquisition of Myricx Bio isn't just a deal. It's a story of academic grit, venture capital vision, and a new blueprint for patient-centric cancer therapy.

Beyond software, a new breed of venture capital is funding America's industrial rebirth, pouring millions into AI, robotics, and the factories of the future.